Nevertheless, summarizing the effects on cardiovascular disease, NF-κB, and platelet activation of this natural product is worthy of review, and additional studies must be conducted to confirm the toxicological properties of this novel molecule before taking place in clinical studies in patients. This evidence concerns the gene NFKB1 and cardiovascular disorder.